ProShare Advisors’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $118K | Sell |
|
|||||
|
2025
Q1 | $140K | Sell |
|
|||||
|
2024
Q4 | $164K | Buy |
|
|||||
|
2024
Q3 | $149K | Buy |
|
|||||
|
2024
Q2 | $88.4K | Sell |
|
|||||
|
2024
Q1 | $89K | Buy |
|
|||||
|
2023
Q4 | $79.2K | Buy |
|
|||||
|
2023
Q3 | $55.2K | Buy |
|
|||||
|
2023
Q2 | $62.1K | Buy |
|
|||||
|
2023
Q1 | $73.4K | Sell |
|
|||||
|
2022
Q4 | $64.2K | Buy |
|
|||||
|
2022
Q3 | $47K | Buy |
|
|||||
|
2022
Q2 | $64K | Sell |
|
|||||
|
2022
Q1 | $93K | Sell |
|
|||||
|
2021
Q4 | $142K | Buy |
|
|||||
|
2021
Q3 | $135K | Sell |
|
|||||
|
2021
Q2 | $114K | Buy |
|
|||||
|
2021
Q1 | $39K | Sell |
|
|||||
|
2020
Q4 | $47K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $23K | Sell |
|
|||||
|
2019
Q2 | $42K | Sell |
|
|||||
|
2019
Q1 | $81K | Buy |
|
|||||
|
2018
Q4 | $86K | Sell |
|
|||||
|
2018
Q3 | $254K | Sell |
|
|||||
|
2018
Q2 | $203K | Buy |
|
|||||
|
2018
Q1 | $127K | Sell |
|
|||||
|
2017
Q4 | $150K | Buy |
|